Cargando…

Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report

Detalles Bibliográficos
Autores principales:	Özkan, Gülsüm, Bayrakçı, N., Karabağ, S., Güzel, EÇ, Ulusoy, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Nephrology - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236739/ https://www.ncbi.nlm.nih.gov/pubmed/34181144 http://dx.doi.org/10.1007/s11255-021-02889-5

Ejemplares similares

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021)

Syndrome of inappropriate antidiuretic hormone and status epilepticus associated with mRNA-based SARS-CoV-2 vaccination
por: Yang, Ji Won, et al.
Publicado: (2022)

Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?
por: Juric, Ivana, et al.
Publicado: (2021)

Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
por: Arteaga-Müller, Giovanna Yazmin, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination as a Trigger for Perinuclear Antineutrophil Cytoplasmic Antibodies (p-ANCA) Associated With Rapidly Progressive Glomerulonephritis
por: Cano-Gámez, Tábata, et al.
Publicado: (2022)

SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients
por: Wang, Xiaoling, et al.
Publicado: (2022)

Characterization of patients with IgA nephropathy with and without associated minimal change disease
por: Guo, Wei-yi, et al.
Publicado: (2023)

Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
por: Tatar, Erhan, et al.
Publicado: (2021)

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines
por: Wu, Chia-Chao, et al.
Publicado: (2021)

Retinal detachments in a patient with minimal change nephrotic syndrome: Case report and review of the literature
por: Ye, Chunjian, et al.
Publicado: (2023)

Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data
por: Duan, Juntao, et al.
Publicado: (2023)

Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
por: Torigoe, Kenta, et al.
Publicado: (2022)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Severe Hyponatremia Presenting with Minimal Symptoms
por: Lwanga, Anita, et al.
Publicado: (2017)

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
por: Morlidge, Clare, et al.
Publicado: (2021)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era
por: Pattanaik, Debendra, et al.
Publicado: (2022)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Poor Response to Inactivated SARS-CoV-2 Vaccine in Patients With Chronic Liver Disease
por: Cao, Huanhuan, et al.
Publicado: (2022)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination
por: Jongvilaikasem, Pondtip, et al.
Publicado: (2022)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients
por: Zhang, Yue-Miao, et al.
Publicado: (2022)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria
por: Isom, Robert, et al.
Publicado: (2019)

Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023)

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine
por: Salem, Fadi, et al.
Publicado: (2021)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
por: Bayrakci, Nergiz, et al.
Publicado: (2022)

Reduced CoronaVac vaccine antibody response in patients with chronic kidney disease
por: Akpolat, Tekin
Publicado: (2021)

Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
por: Angeletti, Andrea, et al.
Publicado: (2021)

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
por: Alhenc-Gelas, Francois, et al.
Publicado: (2020)

Atypical Hemolytic and Uremic Syndrome Triggered by Infection With SARS-CoV2
por: Kaufeld, Jessica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvnu6frg0qp34d57vlirpg6pok